UNIGE document Scientific Article
previous document  unige:100540  next document
add to browser collection

Effects of Antidiabetic Drugs on Gut Microbiota Composition

Published in Genes. 2017, vol. 8, no. 10
Abstract Gut microbiota forms a catalog of about 1000 bacterial species; which mainly belong to the Firmicutes and Bacteroidetes phyla. Microbial genes are essential for key metabolic processes; such as the biosynthesis of short-chain fatty acids (SCFA); amino acids; bile acids or vitamins. It is becoming clear that gut microbiota is playing a prevalent role in pathologies such as metabolic syndrome; type 2 diabetes (T2D); inflammatory and bowel diseases. Obesity and related diseases; notably type 2 diabetes, induce gut dysbiosis. In this review; we aim to cover the current knowledge about the effects of antidiabetic drugs on gut microbiota diversity and composition as well as the potential beneficial effects mediated by specific taxa. Metformin is the first-line treatment against T2D. In addition to its glucose-lowering and insulin sensitizing effects, metformin promotes SCFA-producing and mucin-degrading bacteria. Other antidiabetic drugs discussed in this review show positive effects on dysbiosis; but without any consensus specifically regarding the Firmicutes to Bacteroidetes ratio. Thus, beneficial effects might be mediated by specific taxa.
PMID: 28973971
Full text
Article (Published version) (226 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Laboratoire de recherche NAFLD et résistance à l'insuline
(ISO format)
MONTANDON, Sophie, JORNAYVAZ, François. Effects of Antidiabetic Drugs on Gut Microbiota Composition. In: Genes, 2017, vol. 8, n° 10. doi: 10.3390/genes8100250 https://archive-ouverte.unige.ch/unige:100540

226 hits

0 download


Deposited on : 2017-12-19

Export document
Format :
Citation style :